Professionals' Treatment Preferences in the Prodromal Phase of Parkinson's Disease: A Discrete Choice Experiment.

ABSTRACT:

Background

In Parkinson's disease (PD), several disease-modifying treatments are being tested in (pre-)clinical trials. To successfully implement such treatments, it is important to have insight into factors influencing the professionals' decision to start disease-modifying treatments in persons who are in the prodromal stage of PD.

Objective

We aim to identify factors that professionals deem important in deciding to a start disease-modifying treatment in the prodromal stage of PD.

Methods

We used a discrete choice experiment (DCE) to elicit preferences of neurologists and last-year neurology residents regarding treatment in the prodromal phase of PD. The DCE contained 16 hypothetical choice sets in which participants were asked to choose between two treatment options

SUBMITTER: van den Heuvel L 

PROVIDER: S-EPMC9398060 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature